This inventor holds 1 USPTO granted patent. Top assignee: Klinge Pharma Gmbh. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Gerd Ulfert Heese: Innovator in Pharmaceutical Formulations
Introduction
Gerd Ulfert Heese is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of edema. His innovative approach has led to the development of a unique medicament that addresses various types of edema and diseases of the venous circulatory system.
Latest Patents
Heese holds a patent for the "Production of pharmaceutical formulations for treatment of edema." This invention involves a medicament containing a standardized dry extract of horse chestnut seeds, which is effective against edema. The process includes manufacturing the dry seed extract into pellets that can be coated for sustained release of the active agent. This method ensures that therapeutic blood levels of triterpene glycosides are achieved. The final product is ideally provided as a hard gelatin capsule or matrix tablet containing the extract pellets. Heese's patent is a testament to his commitment to advancing medical treatments.
Career Highlights
Gerd Ulfert Heese is associated with Klinge Pharma GmbH, where he has been instrumental in developing innovative pharmaceutical solutions. His work has not only contributed to the company's portfolio but has also enhanced the quality of life for patients suffering from venous circulatory issues.
Collaborations
Heese has collaborated with James Tobin, further enriching his research and development efforts. Their partnership exemplifies the importance of teamwork in the innovation process.
Conclusion
Gerd Ulfert Heese's contributions to pharmaceutical formulations demonstrate his dedication to improving healthcare. His innovative patent for treating edema showcases the potential of natural extracts in modern medicine. His work continues to inspire advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile